Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue, net $ 2,083,000 $ 3,365,000
Cost of revenue 5,540,000 2,970,000
Gross profit (deficit) (3,457,000) 395,000
Operating Expenses:    
Research and development 7,456,000 7,144,000
Sales and marketing 5,177,000 6,140,000
General and administrative 5,367,000 5,155,000
Total operating expenses 18,000,000 18,439,000
Loss from operations (21,457,000) (18,044,000)
Interest expense, net (932,000) (898,000)
Change in fair value of warrant liability 4,510,000 2,852,000
Change in fair value of derivative liability   (47,000)
Loss on debt extinguishment (837,000)  
Other expense, net (1,000) (12,000)
Loss before provision for income taxes (18,717,000) (16,149,000)
Provision for income taxes 4,000 2,000
Net loss (18,721,000) (16,151,000)
Deemed dividend on conversion of convertible preferred for common stock (6,360,000)  
Net loss attributable to common stockholders $ (25,081,000) $ (16,151,000)
Net loss per common share- basic (in dollars per share) $ (3.18) $ (82.89)
Net loss per common share- diluted (in dollars per share) $ (3.18) $ (82.89)
Weighted average number of common shares used in computing net loss per common share - Basic (in shares) 7,898,469 194,852
Weighted average number of common shares used in computing net loss per common share - Diluted (in shares) 7,898,469 194,852